Klotho, phosphate and inflammation/ageing in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 27, Issue SUPPL.4, 2012, Pages

  Izquierdo, María C ^a   Perez Gomez, María V ^a   Sanchez Niño, María D ^b   Sanz, Ana B ^b   Ruiz Andres, Olga ^a   Poveda, Jonay ^a   Moreno, Juan Antonio ^a   Egido, Jesús ^a,c,d   Ortiz, Alberto ^a,c,d  

^a 28400 Madrid   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

ageing; inflammation; Klotho; NF kappaB; phosphate

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CYTOKINE; CYTOKINE ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KLOTHO PROTEIN; PHOSPHATE; PHOSPHATE BINDING AGENT; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TWEAK; TWEAK ANTIBODY; UNCLASSIFIED DRUG;

AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DOWN REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; KIDNEY DISEASE; NONHUMAN; ORGAN INJURY; PHOSPHATE BALANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AGING; ANIMALS; GLUCURONIDASE; HUMANS; INFLAMMATION; MICE; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84871845839     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs426     Document Type: Review

References (33)

1. Zoccali C, Ruggenenti P, Perna A et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011; 22: 1923-1930
2. Foley RN, Collins AJ, Herzog CA et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404
3. Navarro-Gonzalez JF, Mora-Fernandez C, Muros M et al. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol 2009; 4: 1646-1654
4. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51
5. Hu MC, Kuro O, Moe OW. The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant 2012; 27: 2650-2657
6. Ortiz A. Hutchinson-Gilford progeria syndrome. N Engl J Med 2008; 358: 2410-2411
7. Rosengardten Y, McKenna T, Grochova D et al. Stem cell depletion in Hutchinson-Gilford progeria syndrome. Aging Cell 2011; 10: 1011-1020
8. Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res 2012; 318: 1040-1048
9. Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450
10. Sanchez-Nino MD, Bozic M, Cordoba-Lanus E et al. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 2012; 302: F647-F657
11. Ohnishi M, Razzaque MS. Dietary and genetic evidence for phosphate toxicity accelerating mammalian ageing. FASEB J 2010; 24: 3562-3571
12. Ohyama Y, Kurabayashi M, Masuda H et al. Molecular cloning of rat Klotho cDNA: markedly decreased expression of Klotho by acute inflammatory stress. Biochem Biophys Res Commun 1998; 251: 920-925
13. Thurston RD, Larmonier CB, Majewski PM et al. Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology 2010; 138: 1384-1394.
14. Cheng MF, Chen LJ, Cheng JT. Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats. J Biomed Biotechnol 2010; 2010: 513853
15. Zhao Y, Banerjee S, Dey N et al. Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 2011; 60: 1907-1916
16. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136
17. Hu MC, Shi M, Zhang J et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 2010; 78: 1240-1251
18. Moreno JA, Izquierdo MC, Sanchez-Nino MD et al. The inflammatory cytokines TWEAK and TNFalpha reduce renal Klotho expression through NFkappaB. J Am Soc Nephrol 2011; 22: 1315-1325
19. Maekawa Y, Ishikawa K, Yasuda O et al. Klotho suppresses TNFalpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 2009; 35: 341-346
20. Wang Y, Kuro O, Sun Z. Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell 2012; 11: 410-417
21. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109-1112
22. Liu F, Wu S, Ren H et al. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 2011; 13: 254-262
23. Sugiura H, Yoshida T, Tsuchiya K et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant 2005; 20: 2636-2645
24. Sugiura H, Yoshida T, Mitobe M et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant 2010; 25: 60-68
25. Haruna Y, Kashihara N, Satoh M et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 2007; 104: 2331-2336
26. Arking DE, Krebsova A, Macek M, Sr et al. Association of human aging with a functional variant of Klotho. Proc Natl Acad Sci USA 2002; 99: 856-861
27. Friedman DJ, Afkarian M, Tamez H et al. Klotho variants and chronic hemodialysis mortality. J Bone Miner Res 2009; 24: 1847-1855
28. Ichikawa S, Imel EA, Kreiter ML et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007; 117: 2684-2691
29. Kuwahara N, Sasaki S, Kobara M et al. HMG-CoA reductase inhibition improves anti-aging Klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Int J Cardiol 2008; 123: 84-90
30. Mitani H, Ishizaka N, Aizawa T et al. In vivo Klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 2002; 39: 838-843
31. Navarro-Gonzalez JF, Mora-Fernandez C, Muros de FM et al. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2272-2279
32. Shantouf R, Budoff MJ, Ahmadi N et al. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol 2008; 28: 275-279
33. Mendoza JM, Isakova T, Ricardo AC et al. Fibroblast Growth Factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 2012; 7: 1155-1162